Evidence map›Paper›PMID 37990173›Full record

ArticleBMC psychiatry2023

Neurophysiological explorations across the spectrum of psychosis, autism, and depression, during wakefulness and sleep: protocol of a prospective case-control transdiagnostic multimodal study (DEMETER).

Valeria Lucarini, Anaëlle Alouit, Delphine Yeh, Jeanne Le Coq, Romane Savatte, Mylène Charre, Cécile Louveau, Meryem Benlaifa Houamri, Sylvain Penaud, Alexandre Gaston-Bellegarde and 19 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06045897 (Determination of EEG Microstates Associated With Mental Disorders in At-Risk States), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06045897 naunknown statusnot on this map

Determination of EEG Microstates Associated With Mental Disorders in At-Risk States (Détermination Des Microétats EEG associés Aux Troubles Psychiques Dans Les États à Risque - DEMETER)

TypeinterventionalSponsorCentre Hospitalier St AnneRan2023 to 2026Enrolled126ConditionsPsychotic Disorders, Autism Spectrum Disorder, Major Depressive Disorder, SchizophreniaArmsEEG 64 channels, Polysomnography 19 electrodes, Light hypnosis, Biological sampling, Virtual reality
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. [A study on electroencephalogram characteristics of depression in patients with aphasia based on resting state and emotional Stroop task].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 2 countries.

Valeria LucariniUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Pathophysiology of psychiatric disorders", GDR 3557-Institut de Psychiatrie, 102-108 Rue de la Santé, Paris, 75014, France.
Anaëlle AlouitUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Stroke: from prognostic determinants and translational research to personalized interventions", Paris, 75014, France.
Delphine YehLaboratoire Mémoire, Cerveau et Cognition, UR7536, Université Paris Cité, Boulogne-Billancourt, F-92100, France.
Jeanne Le CoqGHU Paris Psychiatrie et Neurosciences, Pôle Hospitalo-Universitaire d'évaluation, Prévention, et Innovation Thérapeutique (PEPIT), Paris, France.
Romane SavatteGHU Paris Psychiatrie et Neurosciences, Pôle Hospitalo-Universitaire d'évaluation, Prévention, et Innovation Thérapeutique (PEPIT), Paris, France.
Mylène CharreGHU Paris Psychiatrie et Neurosciences, Pôle Hospitalo-Universitaire d'évaluation, Prévention, et Innovation Thérapeutique (PEPIT), Paris, France.
Cécile LouveauGHU Paris Psychiatrie et Neurosciences, Pôle Hospitalo-Universitaire d'évaluation, Prévention, et Innovation Thérapeutique (PEPIT), Paris, France.
Meryem Benlaifa HouamriGHU Paris Psychiatrie et Neurosciences, Pôle Hospitalo-Universitaire d'évaluation, Prévention, et Innovation Thérapeutique (PEPIT), Paris, France.
Sylvain PenaudLaboratoire Mémoire, Cerveau et Cognition, UR7536, Université Paris Cité, Boulogne-Billancourt, F-92100, France.
Alexandre Gaston-BellegardeLaboratoire Mémoire, Cerveau et Cognition, UR7536, Université Paris Cité, Boulogne-Billancourt, F-92100, France.
Stéphane RioCentre du Sommeil et de la Vigilance, AP-HP, Hôtel-Dieu, Paris, France.
Laurent DrouetCentre du Sommeil et de la Vigilance, AP-HP, Hôtel-Dieu, Paris, France.
Maxime ElbazCentre du Sommeil et de la Vigilance, AP-HP, Hôtel-Dieu, Paris, France.
Jean BecchioCollège International de Thérapies d'orientation de l'Attention et de la Conscience (CITAC), Paris, France.
Sylvain PourchetCollège International de Thérapies d'orientation de l'Attention et de la Conscience (CITAC), Paris, France.
Estelle Pruvost-RobieuxUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Stroke: from prognostic determinants and translational research to personalized interventions", Paris, 75014, France.
Angela MarchiEpileptology and Cerebral Rhythmology, APHM, Timone Hospital, Marseille, France.
Mylène MoyalUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Pathophysiology of psychiatric disorders", GDR 3557-Institut de Psychiatrie, 102-108 Rue de la Santé, Paris, 75014, France.
Aline LefebvreDepartment of Child and Adolescent Psychiatry, Fondation Vallee, UNIACT Neurospin CEA - INSERM UMR 1129, Universite Paris Saclay, Gentilly, France.
Boris ChaumetteUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Pathophysiology of psychiatric disorders", GDR 3557-Institut de Psychiatrie, 102-108 Rue de la Santé, Paris, 75014, France.
Martine GriceIfL-Phonetics, University of Cologne, Cologne, Germany.
Påvel G LindbergUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Stroke: from prognostic determinants and translational research to personalized interventions", Paris, 75014, France.
Lucile DupinINCC UMR 8002, CNRS, Université Paris Cité, Paris, F-75006, France.
Pascale PiolinoLaboratoire Mémoire, Cerveau et Cognition, UR7536, Université Paris Cité, Boulogne-Billancourt, F-92100, France.
Cédric LemogneInserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Service de Psychiatrie de l'adulte, AP-HP, Hôpital Hôtel-Dieu, Université Paris Cité and Université Sorbonne Paris Nord, Paris, France.
Damien LégerCentre du Sommeil et de la Vigilance, AP-HP, Hôtel-Dieu, Paris, France.
Martine GavaretUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Stroke: from prognostic determinants and translational research to personalized interventions", Paris, 75014, France.
Marie-Odile KrebsUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Pathophysiology of psychiatric disorders", GDR 3557-Institut de Psychiatrie, 102-108 Rue de la Santé, Paris, 75014, France.
Anton IftimoviciUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team "Pathophysiology of psychiatric disorders", GDR 3557-Institut de Psychiatrie, 102-108 Rue de la Santé, Paris, 75014, France. anton.iftimovici@ghu-paris.fr.
Université Paris Cité · FRFHU Neurovasc · FRInserm · FRHôtel-Dieu de Paris · FRInstitut de Psychiatrie et Neurosciences de Paris · FRAssistance Publique – Hôpitaux de Paris · FRHôpital de la Timone · FRLaboratoire Mémoire et Cognition · FRUniversity of Cologne · DE

Funding

Agence Nationale de la Recherche ANR-18-RHUS-0014, "PsyCARE"Fondation FondaMental - Fondation Bettencourt-Schueller "Young Talents in Psychiatry 2021"GHU Paris Psychiatrie et Neurosciences GHU-Starting-Grant
6 · The paper itself

Abstract

backgroundQuantitative electroencephalography (EEG) analysis offers the opportunity to study high-level cognitive processes across psychiatric disorders. In particular, EEG microstates translate the temporal dynamics of neuronal networks throughout the brain. Their alteration may reflect transdiagnostic anomalies in neurophysiological functions that are impaired in mood, psychosis, and autism spectrum disorders, such as sensorimotor integration, speech, sleep, and sense of self. The main questions this study aims to answer are as follows: 1) Are EEG microstate anomalies associated with clinical and functional prognosis, both in resting conditions and during sleep, across psychiatric disorders? 2) Are EEG microstate anomalies associated with differences in sensorimotor integration, speech, sense of self, and sleep? 3) Can the dynamic of EEG microstates be modulated by a non-drug intervention such as light hypnosis?

methodsThis prospective cohort will include a population of adolescents and young adults, aged 15 to 30 years old, with ultra-high-risk of psychosis (UHR), first-episode psychosis (FEP), schizophrenia (SCZ), autism spectrum disorder (ASD), and major depressive disorder (MDD), as well as healthy controls (CTRL) (N = 21 × 6), who will be assessed at baseline and after one year of follow-up. Participants will undergo deep phenotyping based on psychopathology, neuropsychological assessments, 64-channel EEG recordings, and biological sampling at the two timepoints. At baseline, the EEG recording will also be coupled to a sensorimotor task and a recording of the characteristics of their speech (prosody and turn-taking), a one-night polysomnography, a self-reference effect task in virtual reality (only in UHR, FEP, and CTRL). An interventional ancillary study will involve only healthy controls, in order to assess whether light hypnosis can modify the EEG microstate architecture in a direction opposite to what is seen in disease. DISCUSSION: This transdiagnostic longitudinal case-control study will provide a multimodal neurophysiological assessment of clinical dimensions (sensorimotor integration, speech, sleep, and sense of self) that are disrupted across mood, psychosis, and autism spectrum disorders. It will further test the relevance of EEG microstates as dimensional functional biomarkers.

trial registrationClinicalTrials.gov Identifier NCT06045897.

Indexed as

Autism Spectrum DisorderAutistic DisorderMajor Depressive DisorderPsychotic DisordersAdolescentAdultBrainCase-Control StudiesDepressionElectroencephalographyHumansSleepWakefulnessYoung AdultAutismDepressionEEG microstatesNeurophysiologyPsychosisSense of selfSensorimotor integrationSleepSpeechVirtual reality

Identifiers

PMID37990173
PMCPMC10662684
OpenAlexW4388846370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.